1cP-LSD
| Clinical data | |
|---|---|
| Other names | 1cP, acid, LSD, Lucy |
| Dependence liability | Low |
| Addiction liability | None |
| Routes of administration | By mouth, under the tongue |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Onset of action | 30 - 60 minutes |
| Duration of action | 8 - 24 hours |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| Chemical and physical data | |
| Formula | C24H29N3O2 |
| Molar mass | 391.515 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
1cP-LSD (N1-(cyclopropylmethanoyl)-lysergic acid diethylamide) is an acylated derivative of lysergic acid diethylamide (LSD), which has been sold as a designer drug. It was first synthesized as a legal-LSD alternative by Lizard Labs, a Netherlands based research chemical laboratory. In tests on mice it was found to be an active psychedelic with similar potency to 1P-LSD.